Azure Biosystems Awarded SelectScience Seal of Quality Award

Press Releases

Dublin, Calif. – August 5, 2022 – Azure Biosystems has earned its first SelectScience® Seal of Quality award, in recognition of outstanding feedback received from scientists globally.

The Azure cSeries Gel Imaging Systems have been awarded a Bronze Seal of Quality in recognition of having received over 50 reviews from scientists globally, with an impressive overall rating of 4.9 out of 5 stars.

bronze seal of quality

“I would like to take this opportunity to thank all our reviewers around the world for sharing their valuable opinions and also to congratulate Azure Biosystems, who have been recognized by the people who matter most, their customers,”

The Azure Imaging Systems (which have replaced the Azure cSeries Imaging Systems) provide fast, flexible imaging for Western blotsgels, and more. Systems are available with multiple imaging modes including chemiluminescence, visible light, fluorescence and laser-based near infrared imaging. Compared to the original cSeries, the Azure Imaging Systems include a new 9 megapixel camera for even higher resolution and faster imaging and offer four-channel detection for multicolor and quantitative fluorescent Western blotting. Visit Azure Biosystems to learn more about the Azure Imaging Series.

Seals of Quality recognize the top 0.1% of products that consistently get the highest customer review ratings on SelectScience®, a leading independent laboratory technology website, and are designed to help scientists see, at a glance, the instruments and services their peers love the most.

There are four levels of Seal of Quality: Platinum, Gold, Silver, and Bronze, differentiated by how many reviews a product has received and its overall average rating. This marks the first Seal of Quality to be awarded to Azure Biosystems. 

Read more reviews on Azure instruments by clicking here. For more about the latest Seal of Quality winners, see the SelectScience website.

For additional information, please visit


Lisa Isailovic, VP of Marketing, Azure Biosystems
(925) 307-7127

Azure Adds Cielo Dx qPCR System for In-vitro Diagnostic Use

Press Releases

Dublin, Calif. – October 27, 2021 –Azure Biosystems, a leading provider of innovative bioanalytical solutions for protein and cell biology, announced today that the company is now authorized to distribute and service the Azure Cielo™ Dx in European Union (EU) countries for in vitro diagnostic (IVD) use. The Azure Cielo™ 3 Dx and the Azure Cielo™ 6 Dx, are real-time PCR systems for 3 and 6 channel nucleic acid detection, respectively. Both systems conform to the EU’s In Vitro Diagnostic Directive (IVDD). These medical device products are also registered with the US FDA for in vitro diagnostic use and have been available for purchase since June 2021.

Since launching in March of 2020, Azure Cielo™ has become part of research labs across world, meeting the global demand for real-time PCR systems. The sensitivity and reproducibility of the Azure Cielo™ have driven the success of Azure Biosystem’s first instrument dedicated to the genomics workflow.

Both Azure Cielo Dx models controlled by a 10.3” touch screen interface, with intuitive software that makes setting up runs and checking run status easy. The compact instrument can transfer data via USB, ethernet or Wi-Fi. For run setup and data analysis, the system comes with Azure Cielo Manager software which offers a complete workflow solution for real time PCR run setup and analysis.

The Azure Cielo™ Dx Systems are expected to begin shipping to Europe in October 2021.

For more information, contact, (925) 307-7127

About Azure Biosystems

Azure Biosystems Inc. is an innovative life science platform company that designs, develops, and markets state-of-the-art instruments, including the cSeries imaging platforms. Azure Biosystems’ experienced team has developed 2nd and 3rd generation imaging systems for the life science market, thus applying their technical and market knowledge in creating innovative industry standard setting platforms.

For additional information, please see



Lisa Isailovic
(925) 307-7127